 Connection
Mark Roback to Risk Assessment
This is a "connection" page, showing publications Mark Roback has written about Risk Assessment.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.041 |
|
|
|
-
Ward DS, Williams MR, Berkenbosch JW, Bhatt M, Carlson D, Chappell P, Clark RM, Constant I, Conway A, Cravero J, Dahan A, Dexter F, Dionne R, Dworkin RH, Gan TJ, Gozal D, Green S, Irwin MG, Karan S, Kochman M, Lerman J, Lightdale JR, Litman RS, Mason KP, Miner J, O'Connor RE, Pandharipande P, Riker RR, Roback MG, Sessler DI, Sexton A, Tobin JR, Turk DC, Twersky RS, Urman RD, Weiss M, Wunsch H, Zhao-Wong A. Evaluating Patient-Centered Outcomes in Clinical Trials of Procedural Sedation, Part 2 Safety: Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research Recommendations. Anesth Analg. 2018 11; 127(5):1146-1154.
Score: 0.020
-
Bhatt M, Roback MG, Joubert G, Farion KJ, Ali S, Beno S, McTimoney CM, Dixon A, Dubrovsky AS, Barrowman N, Johnson DW. The design of a multicentre Canadian surveillance study of sedation safety in the paediatric emergency department. BMJ Open. 2015 May 29; 5(5):e008223.
Score: 0.016
-
Wathen JE, Roback MG, Mackenzie T, Bothner JP. Does midazolam alter the clinical effects of intravenous ketamine sedation in children? A double-blind, randomized, controlled, emergency department trial. Ann Emerg Med. 2000 Dec; 36(6):579-88.
Score: 0.006
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|